86 related articles for article (PubMed ID: 11721429)
41. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
42. [Cyclin D2 expression in chronic myelogenous leukemia].
Song JM; Xu D; Fan EJ; Xu SR; Li D; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):103-5. PubMed ID: 14990053
[TBL] [Abstract][Full Text] [Related]
43. [Detection of human cyclin C gene expression in childhood acute lymphocytic leukemia using real-time fluorescence quantitative PCR].
Zhang ZX; Cao LZ; Huang Q; Yang MH; Wang Z; Yu Y
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):14-6. PubMed ID: 18289462
[TBL] [Abstract][Full Text] [Related]
44. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
45. [The relationship between the expression of transferrin receptors (TfR) on leukemia cells and the cell proliferation and iron metabolism status in childhood acute leukemias].
Huang G; Liao Q; Luo C
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):134-6. PubMed ID: 11601239
[TBL] [Abstract][Full Text] [Related]
46. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
[TBL] [Abstract][Full Text] [Related]
47. Farnesyltransferase inhibitors: molecular evidence of therapeutic efficacy in acute lymphoblastic leukemia through cyclin D1 inhibition.
Costa CB; Casalta-Lopes J; Andrade C; Moreira D; Oliveira A; Gonçalves AC; Alves V; Silva T; Dourado M; Nascimento-Costa JM; Sarmento-Ribeiro AB
Anticancer Res; 2012 Mar; 32(3):831-8. PubMed ID: 22399601
[TBL] [Abstract][Full Text] [Related]
48. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
49. Cyclin D1 expression in acute leukemia.
Aref S; Mabed M; El-Sherbiny M; Selim T; Metwaly A
Hematology; 2006 Feb; 11(1):31-4. PubMed ID: 16522546
[TBL] [Abstract][Full Text] [Related]
50. Requirement for cyclin D3 in lymphocyte development and T cell leukemias.
Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P
Cancer Cell; 2003 Dec; 4(6):451-61. PubMed ID: 14706337
[TBL] [Abstract][Full Text] [Related]
51. The subcellular distribution of cyclin-D1 and cyclin-D3 within human islet cells varies according to the status of the pancreas donor.
Taniguchi K; Russell MA; Richardson SJ; Morgan NG
Diabetologia; 2015 Sep; 58(9):2056-63. PubMed ID: 26055066
[TBL] [Abstract][Full Text] [Related]
52. The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells.
Chaves-Ferreira M; Krenn G; Vasseur F; Barinov A; Gonçalves P; Azogui O; Cumano A; Li Z; Pellegrini S; Rocha B; Laderach D
Biol Direct; 2016 Apr; 11():21. PubMed ID: 27129404
[TBL] [Abstract][Full Text] [Related]
53. Survivin and cyclin E2 genes expression in a cohort of Egyptian acute leukemia patients: Clinical importance and future prospects.
Makhlouf MM
Cancer Biomark; 2016; 16(1):181-9. PubMed ID: 26600399
[TBL] [Abstract][Full Text] [Related]
54. Cyproheptadine displays preclinical activity in myeloma and leukemia.
Mao X; Liang SB; Hurren R; Gronda M; Chow S; Xu GW; Wang X; Beheshti Zavareh R; Jamal N; Messner H; Hedley DW; Datti A; Wrana JL; Zhu Y; Shi CX; Lee K; Tiedemann R; Trudel S; Stewart AK; Schimmer AD
Blood; 2008 Aug; 112(3):760-9. PubMed ID: 18502826
[TBL] [Abstract][Full Text] [Related]
55. Role of interleukin-7 in the growth of acute lymphoblastic leukemia.
Touw IP; Pouwels K; van Agthoven AJ; van Gurp R; Delwel R; Hagemeijer A; Hählen K; Löwenberg B
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():36-8. PubMed ID: 2390640
[No Abstract] [Full Text] [Related]
56. Analysis of gamma globin chain composition in childhood acute lymphocytic leukemia (ALL).
Iolascon A; Pinto L; Di Tullio MT; Cutillo S
Haematologica; 1988; 73(6):445-8. PubMed ID: 3148505
[No Abstract] [Full Text] [Related]
57. [Preleukemia in acute childhood lymphoblastic leukemia. Apropos of 3 cases].
López-Ibor B; Aracil J; Bernacer M; Contra T; Gil C; López J; Martín N; Melero C; Valverde F; Vecilla C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():148-50. PubMed ID: 3214026
[No Abstract] [Full Text] [Related]
58. Expression of cyclin A in childhood acute lymphoblastic leukemia cells reveals undisturbed G1-S phase transition and passage through the S phase.
Hirt A; Schmid AM; Julmy F; Schmitz NM; Leibundgut K
Leukemia; 2009 Feb; 23(2):414-7. PubMed ID: 18668132
[No Abstract] [Full Text] [Related]
59. No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells.
Weng AP; Aster JC
Cancer Cell; 2003 Dec; 4(6):417-8. PubMed ID: 14706330
[TBL] [Abstract][Full Text] [Related]
60. [Preliminary investigation on screening for serum protein markers by protein microchips technology in childhood acute lymphocytic leukemia].
Ge YP; Liu WJ; Chen HY
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):552-3. PubMed ID: 19099820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
